Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
10.65
+0.48 (4.72%)
Nov 9, 2026, 9:56 AM EST - Market open
Absci Market Cap
Absci has a market cap or net worth of $1.83 billion as of November 9, 2026. It is the 7,128th most valuable company in the world and the 1,844th biggest in the United States. Its market cap has increased by 266.52% in one year.
Market Cap
1.83B
Enterprise Value
1.63B
1-Year Change
266.52%
Global Rank
Country Rank
#1,844 United States
Category
ChartMarket Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $1.83B, an increase of 331.88%. That is a compound annual growth rate of 31.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 1.83B | 248.27% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.84B |
| Mesoblast | 1.81B |
| Novavax | 1.78B |
| Lycia Therapeutics | 1.76B |
| Agios Pharmaceuticals | 1.76B |
| Stoke Therapeutics | 1.74B |
| SELLAS Life Sciences Group | 1.70B |
| Kailera Therapeutics | 1.68B |